These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31057085)

  • 21. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
    Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
    West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study.
    Teja B; Bosch NA; Wijeysundera DN; Wijeysundera HC; Saskin R; Hill AD; Stelfox HT; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2022 Oct; 19(10):1713-1721. PubMed ID: 35709214
    [No Abstract]   [Full Text] [Related]  

  • 23. A global perspective on vasoactive agents in shock.
    Annane D; Ouanes-Besbes L; de Backer D; DU B; Gordon AC; Hernández G; Olsen KM; Osborn TM; Peake S; Russell JA; Cavazzoni SZ
    Intensive Care Med; 2018 Jun; 44(6):833-846. PubMed ID: 29868972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock.
    Bitton E; Zimmerman S; Azevedo LCP; Benhamou D; Cecconi M; De Waele JJ; Lipman J; Martin-Loeches I; Pirracchio R; Scheeren TWL; Leone M; Einav S
    J Crit Care; 2022 Apr; 68():144-154. PubMed ID: 34895959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock.
    Patel VV; Sullivan JB; Cavanaugh J
    J Pharm Pract; 2023 Feb; 36(1):15-18. PubMed ID: 33752492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
    DeMott JM; Patel G; Lat I
    Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity?
    Hartemink KJ; Groeneveld AB
    Inflammation; 2012 Feb; 35(1):206-13. PubMed ID: 21347606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The definition of septic shock: implications for treatment.
    Marik PE; Lipman J
    Crit Care Resusc; 2007 Mar; 9(1):101-3. PubMed ID: 17352674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 36. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
    Conrad M; Perez P; Thivilier C; Levy B
    J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septic shock in intensive care units. Current focus on treatment].
    Arriagada S D; Donoso F A; Cruces R P; Díaz R F
    Rev Chil Pediatr; 2015; 86(4):224-35. PubMed ID: 26323988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From a pressure-guided to a perfusion-centered resuscitation strategy in septic shock: Critical literature review and illustrative case.
    Gazmuri RJ; de Gomez CA
    J Crit Care; 2020 Apr; 56():294-304. PubMed ID: 31926637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose vasoactive agents in aeromedical retrievals for septic shock: A role for vasopressin?
    Aston B; Allen K; Hamilton A
    Emerg Med Australas; 2023 Apr; 35(2):344-346. PubMed ID: 36513119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.